Herman Poon

Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.

Invest Toronto, Inc. engages in marketing and promotion activities to increase business investment. Its services include complimentary concierge service for businesses, interactions with sector experts and all three levels of government, guidance on site location and selection, business-to-business linkages, and industry and economic benchmarking analysis. The company was founded in 2010 and is headquartered in Toronto, Canada.